AHA: IV Antiplatelet Drug No CHAMPION (CME/CE)

ORLANDO (MedPage Today) The novel fast-acting intravenous antiplatelet agent cangrelor given at the time of PCI or stenting did not reduce the rate of death, MI, or ischemia-driven revascularization at 48 hours compared with clopidogrel (Plavix), results of two trials showed.

source : www.medpagetoday.com

Related News:

• SSRI and Tamoxifen Increase Mortality Risk (CME/CE)
• AAPM: Capsaicin Patch Unaffected by Anesthestics (CME/CE)
• AAPM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AAPM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• HRT Linked to Asthma Risk (CME/CE)
• AM: Facet Graft Quells Refractory Back Pain (CME/CE)
• AM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• AM: Help for Pain and Mood in Fibromyalgia (CME/CE)
• Older Women with Gout at Risk of MI (CME/CE)

Details :
Submited at Sunday, November 15th, 2009 at 1:00 pm on Cardiology by chuck
Comment RSS 2.0 - leave a comment - trackback